CJC-1295 without DAC (2mg/5mg/10mg) is a synthetic growth hormone–releasing hormone (GHRH) analogue studied in peptide research involving endocrine signaling and hormonal regulation pathways. Unlike the DAC-modified version, this peptide doesnot contain the Drug Affinity Complex, resulting in a shorter activity window that allows researchers to examine more controlled and pulsatile signaling patterns in experimental models.
Each vial contains2mg/5mg/10mg of high-purity CJC-1295 without DAC in lyophilized form, allowing researchers to investigate peptide behavior within controlled laboratory environments.
All compounds supplied byFubonzoare intendedstrictly for laboratory research purposes only.